SARS-CoV-2 omicron variant: epidemiological features, biological characteristics, and clinical significance

Y Guo, J Han, Y Zhang, J He, W Yu, X Zhang… - Frontiers in …, 2022 - frontiersin.org
The SARS-CoV-2 Omicron (B. 1.1529) variant was designated as a variant of concern (VOC)
by the World Health Organization (WHO) on November 26, 2021. Within two months, it had …

Type I interferons and SARS-CoV-2: from cells to organisms

P Bastard, Q Zhang, SY Zhang, E Jouanguy… - Current Opinion in …, 2022 - Elsevier
Type I interferons (IFNs) have broad and potent antiviral activity. We review the interplay
between type I IFNs and SARS-CoV-2. Human cells infected with SARS-CoV-2 in vitro …

The efficacy of COVID-19 vaccines in chronic kidney disease and kidney transplantation patients: a narrative review

YC Hou, KC Lu, KL Kuo - Vaccines, 2021 - mdpi.com
The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic has posed a
huge threat to global health because of its rapid spread and various mutant variants. Critical …

Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention

E Shirbhate, J Pandey, VK Patel, M Kamal… - Pharmacological …, 2021 - Springer
Angiotensin-converting enzyme (ACE) and its homologue, ACE2, are commonly allied with
hypertension, renin–angiotensin–aldosterone system pathway, and other cardiovascular …

Literature review of omicron: a grim reality amidst COVID-19

S Arora, V Grover, P Saluja, YA Algarni, SA Saquib… - Microorganisms, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) first emerged in Wuhan city in December 2019, and
became a grave global concern due to its highly infectious nature. The Severe Acute …

XBB. 1.5 Kraken cracked: Gibbs energies of binding and biosynthesis of the XBB. 1.5 variant of SARS-CoV-2

ME Popovic - Microbiological research, 2023 - Elsevier
Abstract The SARS-CoV-2 Hydra with many heads (variants) has been causing the COVID-
19 pandemic for 3 years. The appearance of every new head (SARS-CoV-2 variant) causes …

[HTML][HTML] COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms

CR Settanni, G Ianiro, FR Ponziani… - World Journal of …, 2021 - ncbi.nlm.nih.gov
In December 2019 a novel coronavirus disease 2019 (COVID-19), caused by the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2), started spreading from Wuhan city …

Post-COVID syndrome, inflammation, and diabetes

AA Rizvi, A Kathuria, W Al Mahmeed… - Journal of Diabetes and …, 2022 - Elsevier
The raging COVID-19 pandemic is in its third year of global impact. The SARS CoV 2 virus
has a high rate of spread, protean manifestations, and a high morbidity and mortality in …

Role of probiotics in the management of COVID-19: A computational perspective

QV Nguyen, LC Chong, YY Hor, LC Lew, IA Rather… - Nutrients, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) was declared a pandemic at the beginning of 2020,
causing millions of deaths worldwide. Millions of vaccine doses have been administered …

[HTML][HTML] Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications

Z Ma, KY Yang, Y Huang, KO Lui - Journal of Molecular and Cellular …, 2022 - Elsevier
The global propagation of SARS-CoV-2 leads to an unprecedented public health
emergency. Despite that the lungs are the primary organ targeted by COVID-19, systemic …